ICLR logo

ICON PLC

ICLRNASDAQ
๐Ÿ† #633 by market capEarnings Feb 24US Equity
$214.16โ–ฒ $31.18 (+17.04%)
๐ŸŒ™ After hours$213.98โ–ผ 0.08%Regular close ยท extended-hours price shown
๐Ÿ””
Track ICLR
Get earnings, price moves & breaking news on Telegram
Track
24hโ–ฒ 17.0%
7dโ–ฒ 15.7%
14dโ–ฒ 27.0%
30dโ–ฒ 22.1%
ytdโ–ฒ 17.5%
1yโ–ฒ 20.4%
๐ŸฆMarket Cap
$16.52B
Mid Cap
๐Ÿ“ˆRevenue Growth (YoY)
3.0%
Slowing
๐Ÿ“ŠGross Margin
24.2%
Moderate
๐Ÿ’ตFCF Margin
10.6%
Healthy
โš–๏ธP/S Ratio
1.7x
Cheap
Otter Score
68
Fair

Trading Snapshot

Day Range
$195.99 โ€“ $214.62
52-Week Range
$66.57 โ€“ $203.91
Volume (shares)
3,944,352
Avg Volume (shares)
โ€”
Shares Outstanding
77.2M
Next Earnings
2027-02-24

Fundamentals Snapshot

Annual Revenue
$8.25B
Last Q Revenue
$2.06B
P/E Ratio
204.6
P/S Ratio
1.7x
EPS (TTM)
$0.90
Dividend Yield
โ€”
Dilution (1yr)
โˆ’4.0%
ICLR logo

ICON PLC

ICLR
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$8.3Bโ–ผ โˆ’0.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
26.4%โ–ผ โˆ’10.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnโ€™t profitable yet.
$1.0Bโ–ผ โˆ’7.8% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$862Mโ–ผ โˆ’22.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerโ€™s slice.
79.0Mโ–ผ โˆ’4.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
โˆ’$2.9Bโ–ฒ +$156M YoY
StockOtter ยท stockotter.space

About ICON PLC

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿ’งDilutionโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Fair
68/100

Analyst Ratings

โ“˜
Consensus
Buy
24 analysts
Strong Buy5
Buy10
Hold8
Sell1
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

Seeking Alphaยท6h ago

ICON Public Limited Company (ICLR) Q3 2026 Earnings Call Transcript

ICON Public Limited Company ( ICLR ) Q3 2026 Earnings Call October 28, 2026 8:00 AM EDT Company Participants Kate Haven - Vice President of Investor Relations Barry Balfe - CEO & Director Nigel Clerkin - Chief Financial

MarketBeatยท10h ago

What Icon (ICLR) Said on Its Q3 Earnings Call

Icon NASDAQ: ICLR reported third-quarter 2026 results that management said were in line with expectations, citing record net business wins, improving margins and continued investment in technology-enabled clinical develo

Zacks Investment Researchยท1d ago

Icon PLC (ICLR) Q3 Earnings and Revenues Beat Estimates

Icon PLC (ICLR) came out with quarterly earnings of $2.66 per share, beating the Zacks Consensus Estimate of $2.64 per share. This compares to earnings of $3.31 per share a year ago.

Seeking Alphaยท1d ago

Riverwater Partners Sustainable Value Strategy Q3 2026 Portfolio Update

The Sustainable Value Strategy trailed its benchmark, the Russell 2500 Value Index, in the third quarter. New positions include Lineage, Birkenstock, Matador Resources, KBR and ICON. InterDigital, Stevanato Group and Exe

PRNewsWireยท8d ago

Build-A-Bear Workshop Unveils Three Specialty Shop Experiences Coming to New ICON Park Orlando Destination on Nov. 5

All-new immersive spaces featuring Pokรฉmon, Hello Kittyยฎ and Friends, and Promise Petsโ„ข will debut when Build-A-Bear is scheduled to open its most iconic experience on Nov. 5 ST. LOUIS, Oct. 20, 2026 /PRNewswire/ -- Buil

Zacks Investment Researchยท8d ago

Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for

Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.